Book-43278.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Book-43278.Pdf HOW THE COWS TURNED MAD MAXIME SCHWARTZ HOW THE COWS TURNED MAD Translated by Edward Schneider UNIVERSITY OF CALIFORNIA PRESS Berkeley Los Angeles London The publisher gratefully acknowledges the generous contribution to this book provided by the French Ministry of Culture. Comment les vaches sont devenues folles, by Maxime Schwartz, is published in English translation by arrangement with Éditions Odile Jacob, © Éditions Odile Jacob, Mars 2001. © University of California Press Berkeley and Los Angeles, California University of California Press, Ltd. London, England © 2003 The Regents of the University of California Library of Congress Cataloging-in-Publication Data Schwartz, Maxime, 1940–. [Comment les vaches sont devenues folles. English] How the cows turned mad / Maxime Schwartz; translated by Edward Schneider. p. cm. Includes bibliographical references and index. ISBN 0-520-90087-1 1. Prion diseases—History. I. Title. EA644 .P93.53913 2003 616.8'3—dc21 2002075514 CIP Manufactured in the United States of America 10 09 08 07 06 05 04 03 10 987654 321 The paper used in this publication meets the minimum requirements of ANSI/NISO. Z39.48-1992(R 1997) (Permanence of Paper). ' CONTENTS Prologue 1 1: THE SHEEP ARE STRANGELY DIZZY 4 2: MOLECULES AND MICROBES 13 3: MAD DOGS AND EARTHWORMS 18 4: SCRAPIE UNDER THE MICROSCOPE 24 5: CREUTZFELDT, JAKOB, AND OTHERS 31 6: SCRAPIE IS INOCULABLE 38 7: AND GOATS, AND MICE 45 CONTENTS VI 8: SCRAPIE IS CONTAGIOUS 51 9: KURU AND THE FORE PEOPLE OF PAPUA NEW GUINEA 58 10: THE WALL COMES DOWN 67 11: FROM PEARL NECKLACE TO DOUBLE HELIX 73 12: THE PHANTOM VIRUS 81 13: A TRAGEDY IN THE MAKING 87 14: ONE CASE PER MILLION 93 15: PRIONS 98 16: APRIL 1985 104 17: THE “KISS OF DEATH” 110 18: THE RETURN OF THE SPONTANEISTS 119 CONTENTS VII 19: TO GROW—AND TO DIE 128 20: LESSONS LEARNED 136 21: HAVE THE COWS GONE MAD? 142 22: FROM COWS TO HUMANS 153 23: FROM COWS TO SHEEP? FROM HUMANS TO HUMANS? 163 24: THE SECRET IN THE CLOSET 169 25: UNMASKING “THE DISEASE” 176 26: HAVE WE CONQUERED “THE DISEASE”? 180 27: 2001 184 Epilogue 199 Notes 205 CONTENTS VIII Bibliography 215 Chronology 217 Acknowledgments 225 Index 227 PROLOGUE Thus, we see infection in a new light which cannot fail to be a cause of concern for humankind—unless, in the course of its evolution over the centuries, nature has already come upon every opportunity to produce infectious or contagious diseases, which is highly unlikely. Louis Pasteur, 1881 There shall be new diseases. That is an inevitable fact. Another fact, no less inevitable, is that we will never be able to detect them from the outset. By the time we have some idea of those diseases, they will already be fully formed—in their adulthood, so to speak. They will appear like Athena, springing fully armed from the forehead of Zeus. Charles Nicolle, director of the Institut Pasteur of Tunis and winner of the 1928 Nobel Prize for medicine, 1933 UNKNOWN TO THE public at large until recently, Creutzfeldt-Jakob dis- ease (CJD) is now the subject of daily media attention, especially in western Europe. What exactly is this disease that seems to pose a threat to us all? What is the meaning of terms we hear, such as “sporadic,” “in- herited,” “iatrogenic,” and “new variant”? What is CJD’s relationship to “mad cow disease”—bovine spongiform encephalopathy (BSE)— and to the sheep disease known as scrapie? If it can be transmitted from cattle to humans, why not from sheep to humans? As an infectious disease, can it be transmitted from human to human? What is the 1 PROLOGUE 2 causative agent? It is said to be neither a bacterium nor a virus—so what is it? Can it be detected in infected animals or humans? Can it be eliminated with the right drugs? Is there a vaccine? Why have the cows gone mad? If it is due to their animal-based feed, as some assert, can government prohibitions put an end to the epidemic? And in the mean- time, what should we do to protect ourselves? Can we eat beef? Can we drink milk? How many human victims will there be? Dozens? Or hundreds of thousands? Many of us have asked these questions and more. At the moment, unfortunately, science has only partial answers, and the lack of scientific certainty only fuels anxieties—and wild imaginings. In France, the “mad cow crisis” grew to incredible proportions to- ward the end of 2000. It was without doubt a defining event of the final months of the twentieth century. A number of reasons have been sug- gested for this. Setting aside the isolated incidents that have garnered widespread publicity, there were indeed objective reasons for concern: predictions by epidemiologists that there could ultimately be more than a hundred thousand victims in the United Kingdom alone, the grow- ing number of reported cases of BSE in French cattle, and a scientific finding that suggested the disease could be transmitted through blood transfusions. What was broadly viewed as a genuine panic spread throughout Europe with the late November appearance of BSE cases in Germany and Spain, countries previously thought to be untouched by the disease. The collapse of confidence in products of bovine origin spread to all agricultural products. People no longer knew what they could safely eat—and the economic and political consequences are well known. The confusion was exacerbated by a parallel crisis: the transmission of Creutzfeldt-Jakob disease to children who had been treated with human growth hormone. That tragedy surfaced in 1985, when the first cases were identified in the United States. And, sadly, it has continued, especially in France, where new cases come to light each year. The pub- PROLOGUE 3 lic is asking how physician-administered treatments to make these chil- dren grow could infect them with a lethal disease. Creutzfeldt-Jakob disease is frightening because it is always fatal, be- cause it involves the central nervous system and hence the conscious- ness—the very personality—of its victims, and because we all share a vague fear of contracting it at some point from one source or another. Lest we fall prey to obsessive fear, we must rationally assess the often alarmist information that comes our way. Thus, we need to know more about this mysterious illness—“The Disease”—and must try to under- stand where it comes from and how it spreads. When we delve into the origins of this worrisome illness and into the growth of knowledge about it, we find a sort of detective story with its roots in the distant past. It was already lurking in the eighteenth cen- tury. First identified among English sheep, The Disease killed all it touched. It was like a criminal, donning ever-changing disguises to elude its pursuers: We have been on its trail for three centuries. That trail begins in Britain, and continues in many other countries such as France, Germany, the United States, Switzerland, Austria, Israel, Aus- tralia, and two islands at opposite ends of the Earth—Iceland and New Guinea. Our hunt has made use of the latest scientific advances as they emerged, but its route has also led us through Stone Age civilizations. Many times, almost as if it sensed that it was about to be found out, The Disease has counterattacked, claiming many victims and spread- ing fear. Have we finally tracked it down? Many people think so, but others are doubtful. We shall see. 1 THE SHEEP ARE STRANGELY DIZZY THE EIGHTEENTH CENTURY, which was to conclude with the American and French Revolutions, was also the Age of Enlightenment. The convic- tion was growing that scientific progress was intended to enable hu- mans to control the world around us: Had we not learned to control thunderbolts, thanks to the lightning rod? This was the era of Lin- naeus, Buffon, and Diderot, and we began cataloguing nature’s riches and seeking to employ them in a more rational way. This approach was seen particularly in the areas of agriculture and animal husbandry. Improved productivity was the order of the day. Landowners organized and agricultural societies and academies were founded, where questions of farming were discussed and where news and information were exchanged and documents published. In Eng- land, the enclosure policy was broadly implemented, evicting small- scale farmers to the benefit of big landowners and providing the latter with the resources for long-term investment. In the sphere of animal husbandry, major efforts were made to improve feed and conditions, and to select the most productive breeds. Sheep farming was the first beneficiary of this modernization be- cause wool production was a major industry not only in England but 4 THE SHEEP ARE STRANGELY DIZZY 5 throughout Europe. It is estimated that a quarter of the English popu- lation was involved in wool production or the wool trade in one way or another. And that sector was to remain important. Toward the end of the nineteenth century, an eminent French veterinarian, while noting that sheep farming was on the rise for purposes of meat production, wrote this: Wool is among the pillars of the well-being of modern-day societies. We may thus venture to say that the people who produce the most wool will be the richest and perhaps the most powerful. For more than fifty years, wool production has rained showers of gold upon Europe: For Germany and Russia, it has provided hitherto un- known material well-being and the hope of future prosperity. As for England, is it not its countless merinos that must be deemed ac- countable for the wealth of its colonies and the magnificence of its trade beyond compare?1 Given the care lavished upon these wool-bearing creatures, is it any surprise that the diseases that could affect them were also the object of attention? They had to be catalogued in the hope of being able to con- quer them.
Recommended publications
  • Infarto Da Artéria De Percheron: Relato De Caso
    REVISTA BRASILEIRA DE NEUROLOGIA Órgão Oficial do Instituto de Neurologia Deolindo Couto Vol. 56 • Nº 3 • JUL / AGO / SET - 2020 Revista Brasileira de Neurologia » Volume 56 » Nº 3 » JUL/AGO/SET 2020 1 ISSN 0101-8469 CODEN RBNEES ISSN eletrônico: 2447-2573 Acesso pelo LILACS-Express REVISTA BRASILEIRA DE NEUROLOGIA Órgão Oficial do Instituto de Neurologia Deolindo Couto Editorial............................................................................................................................. 4 Pulmonary capacity of patients with total traumatic injury of the brachial plexus submitted to neurotization with the phrenic nerve: a case series................................................................................................... 5 Camilla Fernandes de Melo, Armèle Dornelas de Andrade, Fernando Henrique Souza, Helen Kerlen Bastos Fuzari, Juliana Fernandes, Silvya Nery Bernardino, Daniella Araújo de Oliveira Conhecimento da população sobre Acidente Vascular Cerebral em Torres RS........................................... 11 Valmir Soares Machado, Lidiane de Medeiros Hahn, Maria Isabel Morgan Martins, Luiz Carlos Porcello Marrone Guillain-Barré syndrome: advances and future perspectives................................................................ 15 Rabello, Francisco de AP Cabral Júnior; Pupe, Camila Castelo Branco; Nascimento, Osvaldo JM. Infarto da artéria de Percheron: relato de caso................................................................................ 21 João Carlos Cervelin, Matheus Muller da Rosa, Rafael
    [Show full text]
  • The Tangled Story of Alois Alzheimer
    Bratisl Lek Listy 2006; 107 (910): 343345 343 TOPICAL REVIEW The tangled story of Alois Alzheimer Zilka N, Novak M Institute of Neuroimmunology, AD Centre of Excellence, Slovak Academy of Sciences, Bratislava, Slovakia. [email protected] Abstract In 1907, Bavarian psychiatrist Alois Alzheimer, who is considered to be a founding father of neuropa- thology, was first to describe the main neuropathologic characteristics of the peculiar disease in the brain of a woman showing progressive dementia when she was in her early 50s. Using a newly deve- loped Bielschowskys silver staining method, Alzheimer observed degenerating neurons with bundles of fibrils (neurofibrillary tangles) and miliary foci of silver-staining deposits scattered over the cortex (senile plaques). In 1910 Emil Kraepelin (Alois Alzheimers superior) coined the term Alzheimers disease to distinguish the presenile form of dementia from the more common senile variant. Alzheimers findings were followed up, and soon a number of reports of similar cases appeared in the literature. During the time, both pathological hallmarks of Alzheimers disease became the gold standard for post-mortem diagnosis of the disease. One hundred years later, dementia of Alzheimers type is con- sidered to be one of the most devastating illnesses of old age. Despite intensive research the cause of the disease still remains elusive (Fig. 2, Ref. 17). Key words: Alzheimers disease, Alois Alzheimer, Augusta D, neurofibrillary tangles, senile plaques. Alois Alzheimer was born in June 14, 1864 in Markbreit am pathology of the nervous system, studying in particular the nor- Main in Southern Germany. He commenced the study of medi- mal and pathological anatomy of the cerebral cortex.
    [Show full text]
  • Ethics of Ambient Assisted Living Technologies for Persons with Dementia, © January 2016 DECLARATION
    peter novitzky ETHICSOFAMBIENTASSISTEDLIVINGTECHNOLOGIESFOR PERSONSWITHDEMENTIA ETHICSOFAMBIENTASSISTEDLIVING TECHNOLOGIESFORPERSONSWITHDEMENTIA peter novitzky ThLic., M.A., MSc. A Dissertation submitted in fulfilment of the requirements for the award of Doctor of Philosophy (Ph.D.) to the Dublin City University School of Computing Prof Bert Gordijn Prof Alan F. Smeaton (supervisory panel) January 2016 Peter Novitzky: Ethics of Ambient Assisted Living Technologies for Persons with Dementia, © January 2016 DECLARATION I hereby certify that this material, which I now submit for assessment on the programme of study leading to the award of Ph.D. is entirely my own work, that I have exercised reasonable care to ensure that the work is original, and does not to the best of my knowledge breach any law of copyright, and has not been taken from the work of others save and to the extent that such work has been cited and acknowledged within the text of my work. Signed: ID No.: 12210395 Date: 04/01/2016 ACKNOWLEDGMENTS My first and foremost thanks goes to my supervisors Prof Bert Gordijn, and Prof Alan F. Smeaton. Their contribution to the successful completion of this thesis was invaluable, as was their continuous support during the times of joy but also despair, which cannot be emphasised enough. I would also like to express my thanks to all the people at CLARITY – Centre For Sensor Web Technologies, Dublin City University, and INSIGHT – Centre For Data Ana- lytics who supported me in my work, particularly, Renaat Verbruggen, Eamon Newman, Tim Jacquemard, Deirdre Sheridan, Margaret Malone, Jonny Hobson, as well as many others. I wish to express my deep gratitude to my family, those passed away and alive, who supported or contributed to the success of my work.
    [Show full text]
  • Pdf and Reported If They Occurred
    Peer-Reviewed Journal Tracking and Analyzing Disease Trends Pages 893–1056 EDITOR-IN-CHIEF D. Peter Drotman Associate Editors EDITORIAL BOARD Paul Arguin, Atlanta, Georgia, USA Timothy Barrett, Atlanta, Georgia, USA Charles Ben Beard, Fort Collins, Colorado, USA Barry J. Beaty, Ft. Collins, Colorado, USA Ermias Belay, Atlanta, Georgia, USA Martin J. Blaser, New York, New York, USA David Bell, Atlanta, Georgia, USA Richard Bradbury, Atlanta, Georgia, USA Christopher Braden, Atlanta, Georgia, USA Sharon Bloom, Atlanta, GA, USA Arturo Casadevall, New York, New York, USA Mary Brandt, Atlanta, Georgia, USA Kenneth C. Castro, Atlanta, Georgia, USA Corrie Brown, Athens, Georgia, USA Louisa Chapman, Atlanta, Georgia, USA Charles Calisher, Fort Collins, Colorado, USA Benjamin J. Cowling, Hong Kong, China Michel Drancourt, Marseille, France Vincent Deubel, Shanghai, China Paul V. Effler, Perth, Australia Isaac Chun-Hai Fung, Statesboro, Georgia, USA Anthony Fiore, Atlanta, Georgia, USA Kathleen Gensheimer, College Park, Maryland, USA David Freedman, Birmingham, Alabama, USA Duane J. Gubler, Singapore Richard L. Guerrant, Charlottesville, Virginia, USA Peter Gerner-Smidt, Atlanta, Georgia, USA Scott Halstead, Arlington, Virginia, USA Stephen Hadler, Atlanta, Georgia, USA Katrina Hedberg, Portland, Oregon, USA Matthew Kuehnert, Atlanta, Georgia, USA David L. Heymann, London, UK Nina Marano, Atlanta, Georgia, USA Keith Klugman, Seattle, Washington, USA Martin I. Meltzer, Atlanta, Georgia, USA Takeshi Kurata, Tokyo, Japan David Morens, Bethesda, Maryland, USA S.K. Lam, Kuala Lumpur, Malaysia J. Glenn Morris, Gainesville, Florida, USA Stuart Levy, Boston, Massachusetts, USA Patrice Nordmann, Fribourg, Switzerland John S. MacKenzie, Perth, Australia John E. McGowan, Jr., Atlanta, Georgia, USA Didier Raoult, Marseille, France Jennifer H. McQuiston, Atlanta, Georgia, USA Pierre Rollin, Atlanta, Georgia, USA Tom Marrie, Halifax, Nova Scotia, Canada Frank Sorvillo, Los Angeles, California, USA Nkuchia M.
    [Show full text]
  • Roads to Europe to Roads Heinrich Aigner and the Genesis of of Genesis the and Aigner Heinrich Auditors of Court European the Laura Christine Ulrich Christine Laura
    LAURA CHRISTINE ULRICH QJ-02-15-731-EN-C ROADS TO EUROPE TO ROADS EUROPE TO ROADS EUROPE TO ROADS ROADS TO EUROPE HEINRICH AIGNER AND THE GENESIS OF THE EUROPEAN COURT OF AUDITORS LAURA CHRISTINE ULRICH CHRISTINE LAURA ULRICH CHRISTINE LAURA ULRICH CHRISTINE LAURA ISBN 978-92-9241-998-1 doi:10.2865/759383 Europe Direct is a service to help you find answers to your questions about the European Union Freephone number (*): 00 800 6 7 8 9 10 11 (*) The information given is free, as are most calls (though some operators, phone boxes or hotels may charge you). More information on the European Union is available on the Internet (http://europa.eu). Luxembourg: Publications Office of the European Union, 2016 print ISBN 978-92-9241-998-1 doi:10.2865/759383 QJ-02-15-731-EN-C PDF ISBN 978-92-9241-999-8 doi:10.2865/006480 QJ-02-15-731-EN-N This publication was produced with the support of the European Court of Auditors. Translation of: Wege nach Europa. Heinrich Aigner und die Anfänge des Europäischen Rechnungshofes. © European Union, 2016 Text: Laura Ulrich. Photos: reproduction is authorised provided the source is acknowledged except photos on pages 37 and 55. For these photos permission must be sought directly from the copyright holder. Photos on front cover: © European Union; Photo on back cover: © Sami Sarkis/Getty Image Printed in Italy PRINTED ON ELEMENTAL CHLORINE-FREE BLEACHED PAPER (ECF) LAURA CHRISTINE ULRICH ROADS TO EUROPE HEINRICH AIGNER AND THE GENESIS OF THE EUROPEAN COURT OF AUDITORS HEINRICH AIGNER AND THE GENESIS OF THE EUROPEAN COURT OF AUDITORS 7 FOREWORD VÍTOR CALDEIRA President of the European Court of Auditors Heinrich Aigner (1924-1988), as a Member of the European Parliament, was deeply committed to setting up a comprehensive budgetary control framework at the European level and was the real driving force behind the establishment of the European Court of Auditors.
    [Show full text]
  • Creutzfeldt-Jakob Disease
    Rev Bras Neurol 56(3):25-28, 2020. Historical note Creutzfeldt-Jakob disease: one hundred years of participation in the design of the transmissible spongiform encephalopathies Doença de Creutzfeldt-Jakob: cem anos de participação no desenho das encefalopatias espongiformes transmissíveis M. da Mota Gomes 1 ABSTRACT RESUMO Creutzfeldt and Jakob's disease (CJD) has its initial A doença de Creutzfeldt e Jakob (CJD) tem seu milestone in the publication issued 100 years ago marco inicial na publicação emitida há 100 anos que that precipitated its better clinical-pathological and precipitou seu melhor entendimento clínico- etiological understanding. Now, it is established that patológico e etiológico. Agora, está estabelecido que it belongs to the group of the prion diseases or pertence ao grupo da família das doenças de príons transmissible spongiform encephalopathies family. ou encefalopatias espongiformes transmissíveis. A CJD is itself divided into several types, the most própria CJD se divide em vários tipos, sendo o mais common being sporadic that is further subdivided comum o esporádico que também se subdivide de according to the anatomoclinical expression, but acordo com a expressão anatomoclínica, mas mainly due to its aetiology regarding prionic protein principalmente devido à sua etiologia em relação à or genotype. proteína priônica ou genótipo. Key words- Creutzfeldt-Jakob disease, spongiform Palavras-chave- Doença de Creutzfeldt-Jakob, encephalopathies, prion protein encefalopatias espongiformes, proteína prioníca _______________________________________________________________________________________________________ Associate Professor, Laboratory of History of Psychiatry, Neurology, and Mental Health. Institute of Psychiatry. Institute of Neurology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil Orcid: https://orcid.org/0000-0001-8889-2573 Corresponding author: [email protected] Revista Brasileira de Neurologia » Volume 56 » Nº 3 » JUL/AGO/SET 2020 25 M.
    [Show full text]
  • Recherche De Facteurs Associés À La Maladie D'alzheimer Par
    UNIVERSITE DE LILLE ÉCOLE DOCTORALE BIOLOGIE SANTE FACULTE DE MEDECINE HENRI WAREMBOURG ANNEE 2019 THESE SCIENTIFIQUE POUR L’OBTENTION DU GRADE DE DOCTEUR DE L’UNIVERSITE DE LILLE Recherche de facteurs associés à la maladie d’Alzheimer par réutilisation de base de données massives Présentée et soutenue publiquement le 9 janvier 2019 à 11 heures au Pôle Formation Par Michaël ROCHOY JURY Président Monsieur le Professeur Gilles CHATELLIER Rapporteurs Monsieur le Professeur Pierre KROLAK-SALMON Madame le Professeur Lamiae GRIMALDI-BENSOUDA Examinatrice Madame le Professeur Florence PASQUIER Directeurs de thèse Monsieur le Professeur Régis BORDET Monsieur le Professeur Emmanuel CHAZARD Avertissement La Faculté de médecine, l’École Doctorale et l’Université de Lille n’entendent donner aucune approbation aux opinions émises dans les thèses. Celles-ci sont propres à leurs auteurs. Remerciements A mon Président de jury, Monsieur le Professeur Gilles CHATELLIER Professeur des Universités Biostatistiques et informatique médicale Unité de recherche INSERM CIC 1418 - Pathologies cardiovasculaires, rénales, endocriniennes Université Paris Descartes Praticien hospitalier Département d’informatique médicale, biostatistiques et santé publique Hôpital Européen Georges Pompidou, AP-HP, Paris Ouest Vous me faites l’honneur de juger mon travail et présider le jury de cette thèse. Je vous remercie pour votre disponibilité et l’amabilité que vous avez eue à mon égard lors de nos précédents échanges. Veuillez trouver ici la marque de mon sincère respect. A mes rapporteurs, Monsieur le Professeur Pierre KROLAK-SALMON Professeur des Universités - Praticien Hospitalier Neurologue et gériatre Directeur médical de l’Institut du vieillissement Responsable du Centre Mémoire de Ressource et de Recherche de Lyon Responsable du Centre de Recherche Clinique « Vieillissement - Cerveau - Fragilité » Président de la Fédération Nationale des CMRR Hospices civils de Lyon - Université de Lyon Vous avez suivi mon travail au fil des comités de suivi et me faites l’honneur ce jour de le juger.
    [Show full text]
  • Biographie Hermann Josephy
    Universitätsklinikum Hamburg-Eppendorf Institut für Geschichte und Ethik der Medizin Direktor: Prof. Dr. med. Heinz-Peter Schmiedebach Leben und Arbeit des Neuropathologen Hermann Josephy (1887-1960) Sowie eine Einführung in die Geschichte der deutschen Neuropathologie Dissertation zur Erlangung des Grades eines Doktors der Humanmedizin der Medizinischen Fakultät der Universität Hamburg. vorgelegt von: Jan-Patrick Stellmann aus Düsseldorf Hamburg 2010 Angenommen von der Medizinischen Fakultät der Universität Hamburg am: 18.05.2011 Veröffentlicht mit Genehmigung der Medizinischen Fakultät der Universität Hamburg. Prüfungsausschuss, der/die Vorsitzende: Prof. Dr. H.-P. Schmiedebach Prüfungsausschuss, zweite/r Gutachter/in: PD Dr. M. Goering Prüfungsausschuss, dritte/r Gutachter/in: Prof. Dr. C. Heesen 1 Inhalt 1 Einleitung 5 1.1 Fragestellung 5 1.2 Forschungsgegenstand und -ziele 5 1.3 Begriffsproblematik „jüdische Deutsche“ und „jüdische Wissenschaftler“ 7 1.4 Forschungsstand, Quellenlage und Methodik 9 1.4.1 Forschungsstand 9 1.4.2 Quellenlage 11 1.4.3 Methodisches Vorgehen 12 2 Einführung in die deutsch-jüdische Geschichte 13 3 Biographie 20 3.1 Einleitung 20 3.2 Josephys Familie, ihre Herkunft und ihr Umfeld 21 3.3 Erziehung und Ausbildung 26 3.3.1 Schwaan - Volksschule 26 3.3.2 Rostock - Gymnasium 27 3.3.3 Studium 29 3.4 Beruflicher Werdegang in Deutschland 40 3.4.1 Rostock 40 3.4.2 Erster Weltkrieg 43 3.4.3 Hamburg 46 3.5 Ausgrenzung und Verfolgung 55 3.6 Auswanderung, Flucht und Tod 71 3.7 England 78 3.8 Amerika 88 3.9 Resümee der
    [Show full text]
  • Urology Swastika
    Edited by Dirk Schultheiss Friedrich H. Moll UROLOGY under the SWASTIKA Foreword It is a great pleasure to write a foreword for this It altered the whole life and career path of many impressive body of work and we would like to urologists, not only during their training and congratulate Dirk Schultheiss and Friedrich Moll formative years, but also as established practitioners. for coordinating and editing this. It is clear that the authors have put an immense amount of effort This interesting and unique book documents the and research into this topic. This book epitomises consequences of this, with reference to the countries the tremendous expertise and dedication which involved in this global catastrophe. It is a fascinating members of the EAU’s History Office devote to academic achievement which provides new insight contributing to our understanding of the past of our into the complexities of practice in Europe and field, in such a passionate fashion. beyond during this time. It is clear that the rise of national socialism and As ever, looking at the past provides us with very fascism in Europe, the subsequent occupation of valuable lessons for the future. We feel that this the continent by the Nazi-regime and the enormous salutatory and very insightful document has an disruption that occurred during World War Two important place on everyone’s bookshelf. We hope had a huge influence on urology and its practice. you enjoy reading it as much as we did. Christopher Chapple EAU Secretary General Manfred Wirth EAU Executive Member, Communication I 5 Introduction L’histoire est un roman dont le peuple est l’auteur.
    [Show full text]
  • アルツハイマー病の発見者:Alois Alzheimer
    保健医療学雑誌 6 (2) ■ 資料 アルツハイマー病の発見者:Alois Alzheimer Discoverer of Alzheimer’s disease: Alois Alzheimer 渡辺 正仁 1) Masahito Watanabe 1) 1) 関西福祉科学大学保健医療学部リハビリテーション学科 〒582-0026 大阪府柏原市旭ヶ丘3丁目11番1号 Tel: 072-947-3737 Fax: 072-978-0377 E-mail: [email protected] 1) Department of Rehabilitation Sciences, Faculty of Allied Health Sciences, Kansai University of Welfare Sciences 3-11-1 Asahigaoka, Kashiwara-shi, Osaka, 582-0026, Japan. TEL +81-72-978-0088 保健医療学雑誌 6 (2): 56-61, 2015. 受付日 2015 年 8 月 5 日 受理日 2015 年 9 月 5 日 JAHS 6 (2): 56-61, 2015. Submitted Aug. 5, 2015. Accepted Sep. 5, 2015. ABSTRACT: Alzheimer disease is a very important neurodegenerative disorder, especially in Japan because we face an unprecedented aging society. Although name of Alzheimer disease itself is very famous, but its discoverer Alois Alzheimer who is a German neurologist is not well-known in Japan. In this paper, the author briefly described his biography about all through his life based on overseas literature. Key words: Alzheimer disease, Alois Alzheimer, biography 要旨: アルツハイマー病(Alzheimer disease)は,今や認知症の約 70%を占めると言われる病気で,超高齢社会を迎えた わが国では重要な位置を占める病気となっている.この病気は 51 歳と若くして亡くなった認知症の患者 Auguste Deter の脳組織を Alzheimer が銀染色で染め,神経細胞内と神経細胞間に特殊な変化を見出したことで命名された.この病名 は余りにも有名であるが,Alzheimer その人に関しては日本ではそれほど知られていない.本稿では Alzheimer の生い 立ちから,数々の人々との出会い,そして死に至るまでを海外の文献を基に紹介する. キーワード:アルツハイマー病, Alois Alzheimer, 伝記 56 保健医療学雑誌 6 (2) 1864-1915)に由来する.Alzheimer に関する紹介 はじめに はいくつかの外国文献でなされているが 1-5),わ が 2013 年(平成 25 年)6 月 1 日の朝日,読売, 国ではその病名の有名さに比して,Alzheimer 自 日経などの主要な新聞に厚生労働省研究班(代表 身については殆ど知られていないのが現状であ
    [Show full text]
  • Histoire De La Découverte Du Cerveau Et Del'évolution Des Méthodes D
    Histoire de la découverte du cerveau et del’évolution des méthodes d’exploration G. Gandolfo, Olivier Deschaux To cite this version: G. Gandolfo, Olivier Deschaux. Histoire de la découverte du cerveau et del’évolution des méthodes d’exploration : De la Préhistoire à nos jours. Biologie Géologie, 2010, 2-2010, pp.127. hal-01090539 HAL Id: hal-01090539 https://hal.univ-cotedazur.fr/hal-01090539 Submitted on 15 Dec 2014 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Histoire des sciences Histoire de la découverte du cerveau et de l’évolution des méthodes d’exploration Première partie : de la préhistoire aux civilisations antiques du pourtour méditerranéen et asiatiques Gabriel Gandolfo et Olivier Deschaux L’histoire des neurosciences montre que la découverte du système nerveux en général et du cerveau en particulier a été chaotique, émaillée de périodes de progrès et de reflux au fil des temps et des cultures. Pour mieux en saisir la portée, chaque étape dans les découvertes est replacée dans le contexte théorique de pensée qui les a présidées et en fonction des méthodes et des techniques d’exploration alors en usage. partir de quel moment de l’Histoire, le cerveau a-t-il suscité l’intérêt de l’Homme ? Quand est-il devenu un sujet d’étude scientifique ? Il est bien Àsûr impossible de répondre avec précision à de telles questions, dans la mesure où nous ne disposons que de fort peu de données fiables surtout pour les temps les plus reculés.
    [Show full text]